To hear about similar clinical trials, please enter your email below
Trial Title:
Role of Positron Emission Tomography in Detecting Primary Tumor in Cases of Metastases of Unknown Origin
NCT ID:
NCT06086652
Condition:
Metastasis of Unknown Origin
Conditions: Official terms:
Neoplasm Metastasis
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
PET/CT
Description:
detection of possible primary tumor
Summary:
In most cases of malignancies, the site of origin of the cancer is clear at presentation
or identified soon after. However, Metastatic cancer of unknown primary site (MUO)
accounts for 3-5% of all malignant neoplasms, and it is defined as metastatic cancer from
an unknown primary site, for which no original site can be detected even after performing
all possible tests. Most common metastatic sites include the liver, lymph nodes, lungs,
and bones.
18F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) allows whole-body tumor
detection and has proven to be useful in patients with metastasis of unknown primary
tumor.
Criteria for eligibility:
Study pop:
Age > 18 years Patients with metastatic tumor. Primary site was not detected with other
radiological examinations Both male and female.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
Age > 18 years Patients with metastatic tumor. Primary site was not detected with other
radiological examinations Both male and female.
Exclusion Criteria:
Patients with known primary tumor Pregnancy. Age < 18 years.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Sohag university Hospital
Address:
City:
Sohag
Country:
Egypt
Status:
Recruiting
Contact:
Last name:
Magdy M Amin, professor
Start date:
September 15, 2023
Completion date:
December 2023
Lead sponsor:
Agency:
Sohag University
Agency class:
Other
Source:
Sohag University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06086652
